SCHEMBL3128366

SCHEMBL3128366

CC(Cn1c(=S)[nH]c(=O)c2[nH]cnc21)NCc1ccc(C(F)(F)F)nc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPO P05164 7/20 0.51
TPO P07202 5/20 0.51
CYP3A4 P08684 2/20 0.42
KCNH2 Q12809 1/20 0.42
ADORA2A P29274 4/20 0.37
PDE4A P27815 3/20 0.37
PDE4B Q07343 3/20 0.37
PDE4C Q08493 3/20 0.37
PDE4D Q08499 3/20 0.37
PNP P00491 1/20 0.37
DAO P14920 2/20 0.36
ADORA2B P29275 2/20 0.36
ADORA3 P0DMS8 1/20 0.36
HPGD P15428 1/20 0.36
ADORA1 P30542 1/20 0.36
BLM P54132 1/20 0.36
PDE3A Q14432 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PDE9A O76083 2/20 0.34
PDE1C Q14123 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL31025166 0.95 MPO (0.47) MPOTPOCYP3A4KCNH2ADORA2A
Trifluoroacetic Acid SCHEMBL2283491 0.95 MPO (0.47) MPOTPOCYP3A4KCNH2ADORA2A
SCHEMBL4041168 0.86 MPO (0.53) MPOTPOCYP3A4KCNH2ADORA2A
Trifluoroacetic Acid SCHEMBL2284280 0.85 MPO (0.48) MPOTPOCYP3A4KCNH2ADORA2A
SCHEMBL2281089 0.82 MPO (0.56) MPOTPOCYP3A4KCNH2ADORA2A
SCHEMBL2283546 0.82 MPO (0.57) MPOTPOCYP3A4KCNH2ADORA2A
SCHEMBL2278995 0.81 MPO (0.52) MPOTPOCYP3A4KCNH2ADORA2A
SCHEMBL2289950 0.79 MPO (0.55) MPOTPOCYP3A4KCNH2ADORA2A
SCHEMBL2287788 0.76 MPO (0.52) MPOTPOCYP3A4KCNH2ADORA2A
SCHEMBL4166941 0.76 MPO (0.60) MPOTPOCYP3A4KCNH2ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2010535-B1 THIOXANTHINE DERIVATIVES AND THEIR USE AS INHIBITORS OF MPO ASTRAZENECA AB (SE) 2012-07-11 EP claimed
EP-2200616-A1 MIPO INHIBITORS FOR THE TREATMENT OF HUNTINGTON'S DISEASE AND MULTIPLE SYSTEM ATROPHY AstraZeneca AB (SE) 2010-06-30 EP disclosed
WO-2009025617-A1 COMBINATIONS CONTAINING MPO INHIBITORS AGAINST NEUROINFLAMMATORY DISORDERS ASTRAZENECA AB (SE) 2009-02-26 WO disclosed
WO-2009025618-A1 MIPO INHIBITORS FOR THE TREATMENT OF HUNTINGTON'S DISEASE AND MULTIPLE SYSTEM ATROPHY ASTRAZENECA AB (SE) 2009-02-26 WO disclosed
EP-2010535-A1 THIOXANTHINE DERIVATIVES AND THEIR USE AS INHIBITORS OF MPO AstraZeneca AB (SE) 2009-01-07 EP disclosed
WO-2007120098-A1 THIOXANTHINE DERIVATIVES AND THEIR USE AS INHIBITORS OF MPO ASTRAZENECA AB (SE) 2007-10-25 WO disclosed